IRIS
ALBISINNI, SIMONE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.948
AS - Asia 3.156
EU - Europa 2.268
SA - Sud America 580
Continente sconosciuto - Info sul continente non disponibili 486
AF - Africa 59
OC - Oceania 6
Totale 12.503
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.739
SG - Singapore 1.380
IT - Italia 1.088
HK - Hong Kong 492
BR - Brasile 470
CN - Cina 421
RU - Federazione Russa 363
BD - Bangladesh 245
VN - Vietnam 224
IE - Irlanda 190
NL - Olanda 180
JP - Giappone 175
DE - Germania 111
GB - Regno Unito 108
CA - Canada 90
IN - India 49
FR - Francia 46
AR - Argentina 36
MX - Messico 32
AT - Austria 27
PL - Polonia 27
TR - Turchia 27
EC - Ecuador 24
ZA - Sudafrica 24
CR - Costa Rica 22
FI - Finlandia 22
ID - Indonesia 22
UA - Ucraina 20
ES - Italia 19
IQ - Iraq 19
IR - Iran 18
JM - Giamaica 15
BE - Belgio 13
MY - Malesia 13
PK - Pakistan 12
SE - Svezia 12
HN - Honduras 11
CL - Cile 10
IL - Israele 10
VE - Venezuela 10
CO - Colombia 9
KR - Corea 9
KE - Kenya 8
NI - Nicaragua 8
PY - Paraguay 8
TN - Tunisia 7
PE - Perù 6
SA - Arabia Saudita 6
AU - Australia 5
CZ - Repubblica Ceca 5
DO - Repubblica Dominicana 5
DZ - Algeria 5
PH - Filippine 5
TT - Trinidad e Tobago 5
AE - Emirati Arabi Uniti 4
GT - Guatemala 4
MA - Marocco 4
NO - Norvegia 4
RS - Serbia 4
UY - Uruguay 4
AZ - Azerbaigian 3
BB - Barbados 3
BG - Bulgaria 3
BS - Bahamas 3
DK - Danimarca 3
GR - Grecia 3
KZ - Kazakistan 3
OM - Oman 3
PA - Panama 3
PR - Porto Rico 3
PT - Portogallo 3
SC - Seychelles 3
UZ - Uzbekistan 3
AL - Albania 2
AO - Angola 2
BO - Bolivia 2
CH - Svizzera 2
CI - Costa d'Avorio 2
EE - Estonia 2
GE - Georgia 2
LT - Lituania 2
LU - Lussemburgo 2
SY - Repubblica araba siriana 2
TW - Taiwan 2
TZ - Tanzania 2
BY - Bielorussia 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
GD - Grenada 1
GH - Ghana 1
GP - Guadalupe 1
GY - Guiana 1
HR - Croazia 1
HU - Ungheria 1
KH - Cambogia 1
KN - Saint Kitts e Nevis 1
LB - Libano 1
LK - Sri Lanka 1
LV - Lettonia 1
MD - Moldavia 1
Totale 12.009
Salva come PNG Salva come JPEG
Città #
Singapore 713
Ashburn 706
San Jose 683
Hong Kong 485
Council Bluffs 258
Woodbridge 234
Wilmington 218
Houston 197
Beijing 192
New York 189
Dublin 188
Center 176
Tokyo 168
Santa Clara 145
Los Angeles 110
The Dalles 104
Milan 95
Ho Chi Minh City 87
Rome 87
Buffalo 86
St. George 85
North Bergen 71
São Paulo 58
Moscow 53
Denver 49
Redondo Beach 49
Chicago 48
Hanoi 47
London 38
Nuremberg 37
Brooklyn 36
Florence 31
Seattle 29
Atlanta 28
Dallas 26
Naples 26
Toronto 24
Warsaw 23
Turin 21
Phoenix 20
Genoa 19
Lauterbourg 18
Mexico City 18
Montreal 18
Orem 18
San José 17
Tehran 17
Zhengzhou 17
Frankfurt am Main 16
Salt Lake City 16
Charlotte 15
Mülheim 15
Boardman 14
Boston 14
Johannesburg 14
Rio de Janeiro 14
Washington 14
Bologna 13
San Francisco 13
Catania 12
Chennai 12
Elk Grove Village 12
Lappeenranta 12
Tampa 12
Verona 12
Amsterdam 11
Jacksonville 11
Philadelphia 11
Shanghai 11
Fairfield 10
Pune 10
Queens 10
Quito 10
Bari 9
Belo Horizonte 9
Brescia 9
Pesaro 9
Poplar 9
Biên Hòa 8
Da Nang 8
Haiphong 8
Istanbul 8
Newark 8
Salvador 8
Ancona 7
Curitiba 7
Guarulhos 7
Guayaquil 7
Juiz de Fora 7
Kingston 7
Las Vegas 7
Miami 7
Pescara 7
San Pedro Sula 7
Schiffdorf 7
Vienna 7
Bragança Paulista 6
Lancaster 6
Madison 6
Managua 6
Totale 6.577
Salva come PNG Salva come JPEG
Nome #
External validation of the Briganti nomogram predicting lymph node invasion in patients with intermediate and high-risk prostate cancer diagnosed with magnetic resonance imaging-targeted and systematic biopsies: A European multicenter study 731
Abdominal obesity as risk factor for prostate cancer diagnosis and high grade disease: A prospective multicenter Italian cohort study 517
THE RELATION BETWEEN OBESITY AND PROSTATE CANCER: THE ROLE OF ABDOMINAL OBESITY AND BODY FRAME 436
18F-JK-PSMA-7 PET/CT for staging intermediate- or high-risk prostate cancer patients before radical prostatectomy: a pilot study 310
Sexual dysfunction due to pudendal neuralgia: A systematic review 187
Clinical experience with 18F-JK-PSMA-7 when using a digital PET/CT 183
Clinical effect of computed guided pudendal nerve block for patients with premature ejaculation: a pilot study 151
New treatment strategies for benign prostatic hyperplasia in the frail elderly population: A systematic review 144
The grade of systemic inflammation, immune inhibition, and gut dysbiosis as prognostic factors for bladder cancer recurrence: a metabolomics approach 125
A systematic review and meta-analysis to evaluate the diagnostic accuracy of PSMA PET/CT in the initial staging of prostate cancer 118
Antibodies targeting prostate-specific membrane antigen positive prostate cancer: from diagnostic imaging to theranostics 116
Prospective per‐target analysis of the added value of the PrecisionPoint Transperineal Access System in cognitive prostate biopsy of MRI targets 105
Radical Nephroureterectomy Tetrafecta: A Proposal Reporting Surgical Strategy Quality at Surgery 104
Metastasis-directed therapy and prostate-targeted therapy in oligometastatic prostate cancer: a systematic review 104
Accuracy of frozen section analysis of urethral and ureteral margins during radical cystectomy for bladder cancer: a systematic review and diagnostic Meta-Analysis 103
Salvage Radical Prostatectomy for Recurrent Prostate Cancer: Morbidity and Functional Outcomes from a Large Multicenter Series of Open versus Robotic Approaches 103
Thromboprophylaxis during neoadjuvant chemotherapy for bladder cancer reduces thromboembolism and bleeding 99
A Territory-wide Study Investigating the Dose and Efficacy of Different Bacillus Calmette-Guérin Strains in Patients with Intermediate- and High-risk Non–muscle-invasive Bladder Cancer 98
CAR-T cell therapy for solid tumors: are we still that far? A systematic review of literature 98
Selecting the Best Candidates for Cisplatin-based Adjuvant Chemotherapy After Radical Cystectomy Among Patients with pN+ Bladder Cancer 95
Pathological features of Prostate Imaging Reporting and Data System (PI-RADS) 3 MRI lesions in biopsy and radical prostatectomy specimens 94
Timing and delay of radical prostatectomy do not lead to adverse oncologic outcomes: results from a large European cohort at the times of COVID-19 pandemic 92
Laparoscopic treatment of pudendal nerve and artery entrapment improves erectile dysfunction in healthy young males 90
Accuracy of elastic fusion biopsy: Comparing prostate cancer detection between targeted and systematic biopsy 89
Oncological and safety profiles in patients undergoing simultaneous transurethral resection (TUR) of bladder tumour and TUR of the prostate 89
Indications for and complications of pelvic lymph node dissection in prostate cancer: accuracy of available nomograms for the prediction of lymph node invasion 87
A systematic review of imaging-guided metastasis-directed therapy for oligorecurrent prostate cancer: revolution or devolution? 87
Immune checkpoint inhibitors for BCG-resistant NMIBC: the dawn of a new era 86
New medical treatments for lower urinary tract symptoms due to benign prostatic hyperplasia and future perspectives 86
Antibody-Drug Conjugates in Prostate Cancer: Where Are we? 86
A systematic review of contemporary management of oligometastatic prostate cancer: fighting a challenge or tilting at windmills? 85
Analysis of predictors of early trifecta achievement after robot-assisted radical prostatectomy for trainers and expert surgeons: the learning curve never ends 85
Restaging transurethral resection in ta high-grade nonmuscle invasive bladder cancer: A systematic review 85
Prognostic value of PlGF upregulation in prostate cancer 85
Fecal microbiota transplantation for immunotherapy-resistant urological tumors: Is it time? An update of the recent literature 84
Enhancing Recovery After Major Bladder Cancer Surgery: Comprehensive Review and Assessment of Application of the Enhanced Recovery After Surgery Guidelines 83
Defining the Morbidity of Robot-Assisted Radical Cystectomy with Intracorporeal Urinary Diversion: Adoption of the Comprehensive Complication Index 83
Incidence, risk factors and outcomes of urethral recurrence after radical cystectomy for bladder cancer: A systematic review and meta-analysis 82
Clinical validation of the intermediate-risk non–muscle-invasive bladder cancer scoring system and substratification model proposed by the International Bladder Cancer Group: A multicenter Young Academic Urologists Urothelial Working Group collaboration 82
Prognostic significance of PI-RADS 5 lesions in patients treated by radical prostatectomy 82
Anterior vs. retzius-sparing robotic assisted radical prostatectomy: can the approach really make a difference? 81
Avelumab as neoadjuvant therapy in patients with urothelial non-metastatic muscle invasive bladder cancer: a multicenter, randomized, non-comparative, phase II study (Oncodistinct 004 - AURA trial) 81
The impact of preoperative venous thromboembolism on patients undergoing TURBT: Perioperative outcomes and healthcare costs from US insurance claims data 81
Transvaginal Natural Orifice Transluminal Endoscopic Surgery (vNOTES) in Urogynecological Surgery: A Systematic Review 79
Management of chronic testicular pain due to thoracolumbar junction syndrome: A pilot study|La prise en charge de la douleur testiculaire chronique due a un syndrome de charniere thoraco-lombaire : étude pilote 79
The train has already left the station: Analyzing the rise of PSMA PET/ CT as new standard for staging high risk prostate cancer 79
Optimizing multiparametric magnetic resonance imaging-targeted biopsy and detection of clinically significant prostate cancer: the role of core number and location 78
External Validation of a Multiparametric Magnetic Resonance Imaging–based Nomogram for the Prediction of Extracapsular Extension and Seminal Vesicle Invasion in Prostate Cancer Patients Undergoing Radical Prostatectomy 77
Continuing acetylsalicylic acid during Robotic-Assisted Radical Cystectomy with intracorporeal urinary diversion does not increase hemorrhagic complications: results from a large multicentric cohort 77
Enhanced Recovery After Surgery for patients undergoing radical cystectomy: Surgeons' perspectives and recommendations ten years after its implementation 77
Current application of the enhanced recovery after surgery protocol for patients undergoing radical cystectomy: lessons learned from European excellence centers 77
Prognosis of patients with T1 low-grade urothelial bladder cancer treated with bacillus Calmette-Guérin immunotherapy 76
Robot-assisted radical cystectomy: towards a future of sexual-sparing surgery? 76
New Technologies for Kidney Surgery Planning 3D, Impression, Augmented Reality 3D, Reconstruction: Current Realities and Expectations 76
Biomarkers for Renal Cell Carcinoma Recurrence: State of the Art 76
Advances in urothelial bladder cancer immunotherapy, dawn of a new age of treatment 75
Compared Efficacy of Adjuvant Intravesical BCG-TICE vs. BCG-RIVM for High-Risk Non-Muscle Invasive Bladder Cancer (NMIBC): A Propensity Score Matched Analysis 74
Cost-analysis of robot-assisted radical cystectomy in Europe: a cross-country comparison 74
Unlocking the Potential of Adequate Bacillus Calmette-Guérin Immunotherapy in Very-high-risk Non–muscle-invasive Bladder Carcinoma: A Multicenter Analysis of Oncological Outcomes and Risk Dynamics 74
Prognostic role of neutrophil-to-lymphocyte ratio (NLR) in urological tumors: an umbrella review of evidence from systematic reviews and meta-analyses 73
Urinary function in female patients after traditional, organ-sparing and nerve-sparing radical cystectomy for bladder cancer: a systematic review and pooled analysis 73
Oncological outcomes of salvage radical prostatectomy for recurrent prostate cancer in the contemporary era: A multicenter retrospective study 72
Reassessment of the efficacy of carboplatin for metastatic urothelial carcinoma in the Era of immunotherapy: a systematic review and meta-analysis 71
Accuracy of elastic fusion biopsy in daily practice: Results of a multicenter study of 2115 patients 69
Predictive factors associated with biochemical recurrence following radical prostatectomy for pathological T2 prostate cancer with negative surgical margins 69
Adjuvant immunotherapy in patients with renal cell carcinoma and urothelial carcinoma: A systematic review and network meta‐analysis 69
A systematic review and meta-analysis comparing the outcomes of open and robotic assisted radical cystectomy 69
Are Italian urologists and nurses ready for electronic instructions for use? A nationwide survey 69
Setting new standards: robot-assisted radical prostatectomy as a day case 69
A prospective clinical trial of HIFU hemiablation for clinically localized prostate cancer 68
68Ga-PSMA PET/CT-based metastasis-directed radiotherapy for oligometastatic prostate cancer recurrence after radical prostatectomy 68
Prevalence of lower urinary tract symptoms in taxi drivers: a cross-sectional web-based survey 68
Prostate cancer, androgen deprivation, and risk of COVID-19 infection: A systematic review and meta-analysis|Cancer de Prostate, déprivation androgénique, et risques d'infection par la COVID-19: revue systématique et méta-analyse 68
Focal therapy for prostate cancer: Making the punishment fit the crime|Thérapie focale pour le cancer de la prostate : une peine correspondante au crime 68
Long-term experience with early single Mitomycin C instillations in patients with low-risk non-muscle-invasive bladder cancer: Prospective, single-centre randomised trial 68
Magnetic Resonance Imaging-Targeted Biopsy and Pretherapeutic Prostate Cancer Risk Assessment: a Systematic Review: Biopsie ciblée par Imagerie par résonance magnétique et évaluation pré-thérapeutique du risque de cancer de la prostate : revue systématique 68
Impact of sex on outcomes after surgery for non-muscle-invasive and muscle-invasive bladder urothelial carcinoma: a systematic review and meta-analysis 68
Uncovering the role of urinary microbiota in urological tumors: a systematic review of literature 67
Variation in Follow-Up after Radical Cystectomy for Bladder Cancer—An Inventory Roundtable and Literature Review 67
Myths, Superstitions, and Popular Beliefs: Do They Still Impact Our Practice? 66
Urinary microbiota and prostatic diseases: the key for the lock? A systematic review 66
Prebiopsy 68Ga-PSMA PET imaging: can we improve the current diagnostic pathway for prostate cancer? 66
Bladder cancer at the time of COVID-19 outbreak 65
Predicting contralateral extraprostatic extension in unilateral high-risk prostate cancer: a multicentric external validation study 65
Contemporary management of benign uretero-enteric strictures after cystectomy: a systematic review 64
Surgical checklist adherence across urology expertise levels impacts transurethral resection of bladder tumour quality indicators 64
Can the success with immunotherapy in metastatic urothelial bladder carcinoma be replicated in the neoadjuvant setting? 64
Systematic review of neoadjuvant therapy by immune checkpoint inhibitors before radical cystectomy: where do we stand? 63
The role of mitomycin C in intermediate-risk non–muscle-invasive bladder cancer: a systematic review and meta-analysis 63
Efficacy of Different Bacillus of Calmette-Guérin (BCG) Strains on Recurrence Rates among Intermediate/High-Risk Non-Muscle Invasive Bladder Cancers (NMIBCs): Single-Arm Study Systematic Review, Cumulative and Network Meta-Analysis 63
Retroperitoneal vs. transperitoneal robotic partial nephrectomy: a multicenter propensity-score matching analysis (PADORA Study - UroCCR n° 68) 62
External validation of models for prediction of side-specific extracapsular extension in prostate cancer patients undergoing radical prostatectomy 62
The optimal number of induction chemotherapy cycles in clinically lymph node‐positive bladder cancer 62
Serum levels of sex hormone binding globulin (SHBG) are not predictive of prostate cancer diagnosis and aggressiveness: results from an Italian biopsy cohort 62
To what extent should we trust statistics? 62
Stratifying patients with intermediate-risk prostate cancer: Validation of a new model based on MRI parameters and targeted biopsy and comparison with NCCN and AUA subclassifications 62
Patterns and predictors of recurrence after open radical cystectomy for bladder cancer: a comprehensive review of the literature 61
Widespread high grade prostatic intraepithelial neoplasia on biopsy predicts the risk of prostate cancer: A 12 months analysis after three consecutive prostate biopsies 60
The role of perilesional and multiparametric resonance imaging-targeted biopsies to reduce the risk of upgrading at radical prostatectomy pathology: A retrospective monocentric study 60
Renorrhaphy techniques in minimally invasive partial nephrectomy: a systematic review of the literature 59
Totale 9.818
Salva come PNG Salva come JPEG
Categoria #
all - tutte 56.455
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.455
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202212 0 0 0 0 0 2 1 0 0 2 1 6
2022/2023806 2 1 1 1 2 628 80 5 14 7 44 21
2023/2024518 14 20 31 16 45 195 60 24 32 21 20 40
2024/20252.993 38 372 192 145 132 214 402 361 446 283 218 190
2025/20264.999 417 319 559 258 417 118 489 649 590 502 424 257
2026/20272.448 338 317 920 858 15 0 0 0 0 0 0 0
Totale 12.503